Altimmune, Inc.ALTNASDAQ
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q4 2025 | 78.01% |
| Q3 2025 | 3.74% |
| Q2 2025 | -5.04% |
| Q1 2025 | 17.74% |
| Q4 2024 | 2.44% |
| Q3 2024 | -11.19% |
| Q2 2024 | 5.33% |
| Q1 2024 | 22.62% |
| Q4 2023 | -4.03% |
| Q3 2023 | -5.17% |
| Q2 2023 | 5.05% |
| Q1 2023 | 19.08% |
| Q4 2022 | -15.29% |
| Q3 2022 | 1.86% |
| Q2 2022 | -0.38% |
| Q1 2022 | 17.21% |
| Q4 2021 | -9.12% |
| Q3 2021 | 13.58% |
| Q2 2021 | -4.24% |
| Q1 2021 | -7.08% |
| Q4 2020 | -2.57% |
| Q3 2020 | 65.80% |
| Q2 2020 | 9.15% |
| Q1 2020 | 15.74% |
| Q4 2019 | -7.90% |
| Q3 2019 | -1.98% |
| Q2 2019 | 8.00% |
| Q1 2019 | -14.61% |
| Q4 2018 | 23.23% |
| Q3 2018 | -33.07% |
| Q2 2018 | 19.86% |
| Q1 2018 | 53.59% |
| Q4 2017 | -47.55% |
| Q3 2017 | 69.34% |
| Q2 2017 | -44.42% |
| Q1 2017 | -37.57% |
| Q4 2016 | 39.22% |
| Q3 2016 | 158.80% |
| Q2 2016 | 20.29% |
| Q1 2016 | 22.29% |